Draft guidance documents published Friday morning by the U.S. Food and Drug Administration, in compliance with actions outlined in its FDASIA Health IT Report, propose both to regulate medical device accessories based on risks they present when used as intended with their parent devices and not regulate products intended only for general wellness.
